What is EXHI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.02B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for EXHI?

P/E (TTM) is n/a and 52-week range is $0.17 to $1.05 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s EXHI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is Exlites Holdings International Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Tampa, Oklahoma, US, ISIN US30207P3001 when available from company profile and filing metadata.

Exlites Holdings International Inc (EXHI) Stock Analysis & Quote

Please enable JavaScript to continue using this application.

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Exlites Holdings International, Inc. engages in the consumer healthcare market and medical supply business. The Company’s customers include both consumer distributors and medical distributors. The firm also contracts manufacturers for a select few medical companies. These products include consumer and medical products. The firm offers patented, patent-pending and proprietary products. The firm sells a variety of proprietary patented and patent-pending healthcare products, such as the Deep Vein Thrombosis (DVT) unit, Transcutaneous electrical nerve stimulation (TEMS) unit, Electronic Muscle Stimulation (EMS) unit, various bracing products and other medical and consumer healthcare products. Its consumer products include SlimWave System, Trim and Tone, Infratens and others. Its Post-Operation Knee Brace is designed for post-operative fixation, allowing the doctor to fasten the patient’s leg into extension, and control range of motion as prescribed.

Website

exlitesholdings.us/

IPO

2001-06-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)